Discordance of p53 mutations of synchronous colorectal carcinomas
- PMID: 10697269
- DOI: 10.1038/modpathol.3880024
Discordance of p53 mutations of synchronous colorectal carcinomas
Abstract
It is unclear whether synchronous multiple tumors arise from multicentric or monoclonal origins. To verify the multicentric origin of synchronous colorectal carcinomas at a genetic level, immunohistochemical and molecular techniques were used to determine the p53 alterations in individual lesions of synchronous colorectal carcinomas. This study was based on a total of 32 colorectal tumors from 16 patients. Twenty-one of the 32 (66%) advanced tumors examined had positive staining for p53. Single-strand conformation polymorphism and polymerase chain reaction direct sequencing were carried out for exons 5 to 8 of p53. All cases had p53 mutations in one or more tumors of synchronous lesions. In nine patients in this series, individual lesions were found to carry a different mutated codon of the p53 gene. In the other seven patients, a p53 mutation was found in one tumor but not in another. These results indicate discordance of the mutation pattern of p53 in individual lesions of multiple colorectal carcinomas and support the idea that most synchronous colorectal carcinomas are genetically distinguishable and are multicentric in origin. We also confirmed the high frequency of p53 mutations in left-sided (71%) and rectal (91%) carcinomas, rather than right-sided (43%; P = .04) carcinomas, suggesting that the molecular mechanism of synchronous colorectal carcinomas might differ between right- and left-sided tumors in the same patient.
Similar articles
-
Genetic evidence for the multicentric origin of synchronous multiple gastric carcinoma.Lab Invest. 1997 Mar;76(3):407-17. Lab Invest. 1997. PMID: 9121123
-
Humoral response to p53 is associated with conserved domains II and IV mutations in human colorectal cancer: a case-control study in Taiwan.Oncol Rep. 2004 Nov;12(5):1045-51. Oncol Rep. 2004. PMID: 15492791
-
APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.Am Surg. 2005 Apr;71(4):336-43. Am Surg. 2005. PMID: 15943410
-
[p53 and colorectal cancer].Pathol Biol (Paris). 1997 Dec;45(10):876-81. Pathol Biol (Paris). 1997. PMID: 9769952 Review. French.
-
Genetic changes in colorectal adenoma and cancer in relation to various morphologic aspects.J Gastroenterol. 1998 Dec;33(6):804-10. doi: 10.1007/s005350050179. J Gastroenterol. 1998. PMID: 9853551 Review. No abstract available.
Cited by
-
Humoral immune response to p53 correlates with clinical course in colorectal cancer patients during adjuvant chemotherapy.Int J Colorectal Dis. 2004 Mar;19(2):114-20. doi: 10.1007/s00384-003-0553-5. Epub 2003 Nov 21. Int J Colorectal Dis. 2004. PMID: 14634775
-
Complete single-stage management of left colon cancer obstruction with a new device.Surg Endosc. 2005 Oct;19(10):1381-7. doi: 10.1007/s00464-004-8232-3. Epub 2005 Jul 28. Surg Endosc. 2005. PMID: 16151681 Clinical Trial.
-
Synchronous trifocal colorectal cancer.Proc (Bayl Univ Med Cent). 2016 Oct;29(4):391-392. doi: 10.1080/08998280.2016.11929481. Proc (Bayl Univ Med Cent). 2016. PMID: 27695171 Free PMC article.
-
A systematic review and meta-analysis of somatic and germline DNA sequence biomarkers of esophageal cancer survival, therapy response and stage.Ann Oncol. 2015 Apr;26(4):624-644. doi: 10.1093/annonc/mdu449. Epub 2014 Sep 11. Ann Oncol. 2015. PMID: 25214541 Free PMC article.
-
Collision tumor of the rectum: a case report of metastatic gastric adenocarcinoma plus primary rectal adenocarcinoma.World J Gastroenterol. 2006 Sep 14;12(34):5569-72. doi: 10.3748/wjg.v12.i34.5569. World J Gastroenterol. 2006. PMID: 17007003 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous